Company profile: Carmat
1.1 - Company Overview
Company description
- Provider of biocompatible, auto-regulated bioprosthetic total artificial hearts, including right and left ventricles designed to be as close as possible to the human heart; offers Aeson as an alternative therapeutic option for patients with advanced biventricular heart failure.
Products and services
- Total Artificial Heart Assemblies: Biocompatible, auto-regulated devices with integrated right and left ventricles engineered to be as close as possible to the human heart for healthcare use
- Aeson: Bioprosthetic artificial heart engineered as an alternative therapeutic option for advanced biventricular heart failure, with right and left ventricles designed to mimic human heart behavior
- Bioprosthetic Ventricular Components: Right and left ventricular assemblies developed to be as close as possible to the human heart, supporting biocompatible, auto-regulated total artificial hearts.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Carmat
Proxim Diagnostics
HQ: United States
Website
- Description: Provider of next-generation handheld immunodiagnostic solutions, including a portable device for near-patient whole blood testing with touch-screen and multiple connectivity options, low-cost disposable test cartridges, and a test menu for sepsis, cardiology, and infectious disease (e.g., PCT). Suitable for emergency rooms, ICU, nursing and home care, community and employee clinics, rural and remote clinics, disaster relief, and defense.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proxim Diagnostics company profile →
Corvia Medical
HQ: United States
Website
- Description: Provider of transcatheter structural heart devices for heart failure, including the Corvia Atrial Shunt (InterAtrial Shunt Device) designed to treat diastolic heart failure/HFpEF by reducing pressures in the heart and lungs, supported by clinical evidence and the RESPONDER-HF clinical study assessing efficacy in patients with EF ≥40%.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corvia Medical company profile →
Medos Medizintechnik
HQ: Germany
Website
- Description: Provider of medical devices for cardiac surgery, extracorporeal membrane oxygenation, and ventricle assist devices, offering VAD cannulae, X-Flow, DELTASTREAM, HILITE, HILITE Reservoirs, and tubing sets (machine-sets, table-sets).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medos Medizintechnik company profile →
Epix Therapeutics
HQ: United States
Website
- Description: Provider of microwave radiometry-based electrophysiology products that deliver real-time feedback on energy delivered by catheters during cardiac ablation procedures; develops, manufactures, and commercializes these solutions, with a strategic relationship with Hansen Medical Inc.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epix Therapeutics company profile →
SIS Medical
HQ: Switzerland
Website
- Description: Provider of vascular disease treatment products, developed, produced, and sold through its subsidiaries; founded in 2005 and headquartered in Winterthur, Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SIS Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Carmat
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Carmat
2.2 - Growth funds investing in similar companies to Carmat
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Carmat
4.2 - Public trading comparable groups for Carmat
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →